{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:31:28Z","timestamp":1785821488188,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":184,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1124\/molpharm.124.000881","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T20:05:11Z","timestamp":1716235511000},"page":"56-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Allosteric Inhibition and Pharmacochaperoning of the Serotonin Transporter by the Antidepressant Drugs Trazodone and Nefazodone"],"prefix":"10.1016","volume":"106","author":[{"given":"Ali","family":"El-Kasaby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6200-7158","authenticated-orcid":false,"given":"Danila","family":"Boytsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2947-4803","authenticated-orcid":false,"given":"Ameya","family":"Kasture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0587-9072","authenticated-orcid":false,"given":"G\u00fcnther","family":"Krumpl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9398-1765","authenticated-orcid":false,"given":"Michael","family":"Freissmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3637-260X","authenticated-orcid":false,"given":"Walter","family":"Sandtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/molpharm.124.000881_bib1","doi-asserted-by":"crossref","first-page":"19250","DOI":"10.1074\/jbc.M117.797092","article-title":"Pharmacochaperoning in a Drosophila model system rescues human dopamine transporter variants associated with infantile\/juvenile parkinsonism","volume":"292","author":"Asjad","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.124.000881_bib2","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/npp.2013.331","article-title":"Evidence for a role of transporter-mediated currents in the depletion of brain serotonin induced by serotonin transporter substrates","volume":"39","author":"Baumann","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/molpharm.124.000881_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s002280050076","article-title":"Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and time to attain steady-state plasma concentrations after dose escalation and de-escalation","volume":"50","author":"Barbhaiya","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/molpharm.124.000881_bib4","doi-asserted-by":"crossref","first-page":"22053","DOI":"10.1074\/jbc.M116.749119","article-title":"Pharmacological chaperones of the dopamine transporter rescue dopamine transporter deficiency syndrome mutations in heterologous cells","volume":"291","author":"Beerepoot","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.124.000881_bib5","doi-asserted-by":"crossref","first-page":"16773","DOI":"10.1074\/jbc.M117.794081","article-title":"Conformational state interactions provide clues to the pharmacochaperone potential of serotonin transporter partial substrates","volume":"292","author":"Bhat","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.124.000881_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1042\/BST20180512","article-title":"How to rescue misfolded SERT, DAT and NET: targeting conformational intermediates with atypical inhibitors and partial releasers","volume":"47","author":"Bhat","year":"2019","journal-title":"Biochem Soc Trans"},{"key":"10.1124\/molpharm.124.000881_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1021\/acsptsci.0c00102","article-title":"Tropane-based ibogaine analog rescues folding-deficient serotonin and dopamine transporters","volume":"4","author":"Bhat","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1124\/molpharm.124.000881_bib8","doi-asserted-by":"crossref","first-page":"107785","DOI":"10.1016\/j.pharmthera.2020.107785","article-title":"Functional and biochemical consequences of disease variants in neurotransmitter transporters: a special emphasis on folding and trafficking deficits","volume":"222","author":"Bhat","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1124\/molpharm.124.000881_bib9","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67996","article-title":"Handling of intracellular K+ determines voltage dependence of plasmalemmal monoamine transporter function","volume":"10","author":"Bhat","year":"2021","journal-title":"eLife"},{"key":"10.1124\/molpharm.124.000881_bib10","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.82641","article-title":"A mechanism of uncompetitive inhibition of the serotonin transporter","volume":"12","author":"Bhat","year":"2023","journal-title":"eLife"},{"key":"10.1124\/molpharm.124.000881_bib11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","article-title":"A call for systematic research on solute carriers","volume":"162","author":"C\u00e9sar-Razquin","year":"2015","journal-title":"Cell"},{"key":"10.1124\/molpharm.124.000881_bib12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nature17629","article-title":"X-ray structures and mechanism of the human serotonin transporter","volume":"532","author":"Coleman","year":"2016","journal-title":"Nature"},{"key":"10.1124\/molpharm.124.000881_bib13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF02244985","article-title":"Binding of antidepressants to human brain receptors: focus on newer generation compounds","volume":"114","author":"Cusack","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/molpharm.124.000881_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1755-5949.2008.00067.x","article-title":"Vilazodone: a 5-HT1A receptor agonist\/serotonin transporter inhibitor for the treatment of affective disorders","volume":"15","author":"Dawson","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"10.1124\/molpharm.124.000881_bib15","doi-asserted-by":"crossref","first-page":"39201","DOI":"10.1074\/jbc.M110.118000","article-title":"Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter","volume":"285","author":"El-Kasaby","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.124.000881_bib16","doi-asserted-by":"crossref","first-page":"28987","DOI":"10.1074\/jbc.M114.595090","article-title":"A cytosolic relay of heat shock proteins HSP70-1A and HSP90\u03b2 monitors the folding trajectory of the serotonin transporter","volume":"289","author":"El-Kasaby","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.124.000881_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/164_2017_71","article-title":"SLC6 Transporter folding diseases and pharmacochaperoning","volume":"245","author":"Freissmuth","year":"2018","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/molpharm.124.000881_bib18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2165\/00003088-199733040-00002","article-title":"Clinical pharmacokinetics of nefazodone","volume":"33","author":"Greene","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/molpharm.124.000881_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1124\/mol.115.099036","article-title":"Ligand selectivity among the dopamine and serotonin transporters specified by the forward binding reaction","volume":"88","author":"Hasenhuetl","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.124.000881_bib20","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1021\/jm040793q","article-title":"Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitors","volume":"47","author":"Heinrich","year":"2004","journal-title":"J Med Chem"},{"key":"10.1124\/molpharm.124.000881_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0026-895X(25)08696-1","article-title":"Thiophosphorylation of the G protein \u03b2 subunit in human platelet membranes: evidence against a direct phosphate transfer reaction to G \u03b1 subunits","volume":"49","author":"Hohenegger","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.124.000881_bib22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fphar.2015.00224","article-title":"Pharmacokinetics of single oral dose trazodone: a randomized, two-period, cross-over trial in healthy, adult, human volunteers under fed condition","volume":"6","author":"Kale","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1124\/molpharm.124.000881_bib23","doi-asserted-by":"crossref","first-page":"20876","DOI":"10.1074\/jbc.M116.737551","article-title":"Functional rescue of a misfolded Drosophila melanogaster dopamine transporter mutant associated with a sleepless phenotype by pharmacological chaperones","volume":"291","author":"Kasture","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.124.000881_bib24","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3390\/ijms19061788","article-title":"Big lessons from tiny flies: Drosophila melanogaster as a model to explore dysfunction of dopaminergic and serotonergic neurotransmitter systems","volume":"19","author":"Kasture","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1124\/molpharm.124.000881_bib25","doi-asserted-by":"crossref","first-page":"13263","DOI":"10.1074\/jbc.M115.641357","article-title":"A salt bridge linking the first intracellular loop with the C terminus facilitates the folding of the serotonin transporter","volume":"290","author":"Koban","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.124.000881_bib26","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153408","article-title":"The cell cycle protein MAD2 facilitates endocytosis of the serotonin transporter in the neuronal soma","volume":"24","author":"Koban","year":"2023","journal-title":"EMBO Rep"},{"key":"10.1124\/molpharm.124.000881_bib27","doi-asserted-by":"crossref","first-page":"13439","DOI":"10.1074\/jbc.M511382200","article-title":"The conserved glutamate (Glu136) in transmembrane domain 2 of the serotonin transporter is required for the conformational switch in the transport cycle","volume":"281","author":"Korkhov","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.124.000881_bib28","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1046\/j.1464-410x.2000.00601.x","article-title":"Affinity of trazodone for human penile \u03b11- andalpha2-adrenoceptors","volume":"85","author":"Krege","year":"2000","journal-title":"BJU Int"},{"key":"10.1124\/molpharm.124.000881_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1124\/mol.114.094045","article-title":"Chaperoning of the A1-adenosine receptor by endogenous adenosine - an extension of the retaliatory metabolite concept","volume":"87","author":"Kusek","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.124.000881_bib30","doi-asserted-by":"crossref","first-page":"10919","DOI":"10.3390\/ijms231810919","article-title":"Determining ligand and ion-induced conformational changes in serotonin transporter with its fluorescent substrates","volume":"23","author":"Li","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1124\/molpharm.124.000881_bib31","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1021\/acs.chemrev.8b00532","article-title":"Folding and misfolding of human membrane proteins in health and disease: from single molecules to cellular proteostasis","volume":"119","author":"Marinko","year":"2019","journal-title":"Chem Rev"},{"key":"10.1124\/molpharm.124.000881_bib32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00007691-200208000-00016","article-title":"Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients","volume":"24","author":"Mihara","year":"2002","journal-title":"Ther Drug Monit"},{"key":"10.1124\/molpharm.124.000881_bib33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-0773.1992.tb00535.x","article-title":"Single dose pharmacokinetics of trazodone in healthy subjects","volume":"71","author":"Nilsen","year":"1992","journal-title":"Pharmacol Toxicol"},{"key":"10.1124\/molpharm.124.000881_bib34","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/cts.13253","article-title":"Estimation of brain receptor occupancy for trazodone immediate release and once a day formulations","volume":"15","author":"Oggianu","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1124\/molpharm.124.000881_bib35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7150\/ijms.22643","article-title":"Lipid emulsion for treating local anesthetic systemic toxicity","volume":"15","author":"Ok","year":"2018","journal-title":"Int J Med Sci"},{"key":"10.1124\/molpharm.124.000881_bib36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0278-5846(96)00140-6","article-title":"Plasma concentrations of trazodone and m-chlorophenylpiperazine at steady state can be predicted from those after an initial dose of trazodone","volume":"21","author":"Otani","year":"1997","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/molpharm.124.000881_bib37","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0022-3565(24)37161-7","article-title":"Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites","volume":"283","author":"Owens","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/molpharm.124.000881_bib38","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1038\/s41467-021-25363-3","article-title":"The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter","volume":"12","author":"Plenge","year":"2021","journal-title":"Nat Commun"},{"key":"10.1124\/molpharm.124.000881_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/molpharm.121.000413","article-title":"Thermal unfolding of the human serotonin transporter: differential effect by stabilizing and destabilizing mutations and cholesterol on thermodynamic and kinetic stability","volume":"101","author":"Ponleitner","year":"2022","journal-title":"Mol Pharmacol"},{"key":"10.1124\/molpharm.124.000881_bib40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2015.04.013","article-title":"Widespread macromolecular interaction perturbations in human genetic disorders","volume":"161","author":"Sahni","year":"2015","journal-title":"Cell"},{"key":"10.1124\/molpharm.124.000881_bib41","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1074\/jbc.M111.304261","article-title":"Unifying concept of serotonin transporter-associated currents","volume":"287","author":"Schicker","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.124.000881_bib42","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.tibs.2023.05.011","article-title":"Targeting SLC transporters: small molecules as modulators and therapeutic opportunities","volume":"48","author":"Schlessinger","year":"2023","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/molpharm.124.000881_bib43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/2045125311409486","article-title":"Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor","volume":"1","author":"Schwartz","year":"2011","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1124\/molpharm.124.000881_bib44","series-title":"Enzyme Kinetics: Behaviour and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems","author":"Segel","year":"1975"},{"key":"10.1124\/molpharm.124.000881_bib45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tips.2014.11.006","article-title":"Amphetamines, new psychoactive drugs and the monoamine transporter cycle","volume":"36","author":"Sitte","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/molpharm.124.000881_bib46","doi-asserted-by":"crossref","first-page":"16482","DOI":"10.1074\/jbc.M111.230037","article-title":"The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C","volume":"286","author":"Sucic","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.124.000881_bib47","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1074\/jbc.M112.408237","article-title":"Switching the clientele: a lysine residing in the C terminus of the serotonin transporter specifies its preference for the coat protein complex II component SEC24C","volume":"288","author":"Sucic","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/molpharm.124.000881_bib48","doi-asserted-by":"crossref","first-page":"832536","DOI":"10.3389\/fncel.2022.832536","article-title":"Structure-activity relationships of dopamine transporter pharmacological chaperones","volume":"16","author":"Sutton","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/molpharm.124.000881_bib49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","article-title":"Pharmacological profile of antidepressants and related compounds at human monoamine transporters","volume":"340","author":"Tatsumi","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/molpharm.124.000881_bib50","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1039\/C9CP05764A","article-title":"The binding mode of vilazodone in the human serotonin transporter elucidated by ligand docking and molecular dynamics simulations","volume":"22","author":"Zhang","year":"2020","journal-title":"Phys Chem Chem Phys"},{"key":"10.1124\/molpharm.124.000881_bib51","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/anie.201508755","article-title":"Nanopharmacological force sensing to reveal allosteric coupling in transporter binding sites","volume":"55","author":"Zhu","year":"2016","journal-title":"Angew Chem Int Ed Engl"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24000166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24000166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/molpharm.124.000881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T17:19:29Z","timestamp":1740763169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24000166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0026895X24000166"],"URL":"https:\/\/doi.org\/10.1124\/molpharm.124.000881","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allosteric Inhibition and Pharmacochaperoning of the Serotonin Transporter by the Antidepressant Drugs Trazodone and Nefazodone","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/molpharm.124.000881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The Author(s)","name":"copyright","label":"Copyright"}]}}